| Corrina J Reinek, APRN | |
|
2776 Cleveland Ave, Fort Myers, FL 33901-5864 | |
| (239) 343-2606 | |
| (239) 343-3695 |
| Full Name | Corrina J Reinek |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 2776 Cleveland Ave, Fort Myers, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134602188 | NPI | - | NPPES |
| 101157800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SE0003X | Clinical Nurse Specialist - Emergency | APRN9235194 (Florida) | Secondary |
| 363LG0600X | Nurse Practitioner - Gerontology | APRN9235194 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ies Florida Pllc | 8921485004 | 25 |
News Archive
DST Health Solutions, LLC today announced its 5-I Compliance Accelerator Program, designed to help health plans successfully prepare major business systems for compliance with upcoming federal regulations. Within two years, the Centers for Medicare & Medicaid Services (CMS) will require healthcare organizations to begin using new standards for electronic transactions and within three years new diagnostic and procedure code sets – a regulatory challenge being dubbed "healthcare's Y2K."
Researchers at the University of California, San Diego School of Medicine developed a method to expand the types of chromosomal abnormalities that noninvasive prenatal testing (NIPT) can detect. The study, published November 9 by Proceedings of the National Academy of Sciences, uses a semiconductor sequencing platform to identify small chromosomal deletions or duplications, such as occur in Cri du Chat Syndrome and DiGeorge Syndrome, with a simple blood test from the expectant mother.
Zafgen, Inc., the world's first biopharmaceutical company dedicated to addressing the unmet need of severely obese patients, today announced new data from two Phase 1 studies of beloranib, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed significant weight loss and improvements in cardiometabolic risk markers in severely obese women.
Cronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world's leading experts on lung disease.
› Verified 4 days ago
| Entity Name | Lee Memorial Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992873319 PECOS PAC ID: 8729996608 Enrollment ID: O20031118000604 |
News Archive
DST Health Solutions, LLC today announced its 5-I Compliance Accelerator Program, designed to help health plans successfully prepare major business systems for compliance with upcoming federal regulations. Within two years, the Centers for Medicare & Medicaid Services (CMS) will require healthcare organizations to begin using new standards for electronic transactions and within three years new diagnostic and procedure code sets – a regulatory challenge being dubbed "healthcare's Y2K."
Researchers at the University of California, San Diego School of Medicine developed a method to expand the types of chromosomal abnormalities that noninvasive prenatal testing (NIPT) can detect. The study, published November 9 by Proceedings of the National Academy of Sciences, uses a semiconductor sequencing platform to identify small chromosomal deletions or duplications, such as occur in Cri du Chat Syndrome and DiGeorge Syndrome, with a simple blood test from the expectant mother.
Zafgen, Inc., the world's first biopharmaceutical company dedicated to addressing the unmet need of severely obese patients, today announced new data from two Phase 1 studies of beloranib, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed significant weight loss and improvements in cardiometabolic risk markers in severely obese women.
Cronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world's leading experts on lung disease.
› Verified 4 days ago
| Entity Name | Ies Florida Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124788716 PECOS PAC ID: 8921485004 Enrollment ID: O20220510002828 |
News Archive
DST Health Solutions, LLC today announced its 5-I Compliance Accelerator Program, designed to help health plans successfully prepare major business systems for compliance with upcoming federal regulations. Within two years, the Centers for Medicare & Medicaid Services (CMS) will require healthcare organizations to begin using new standards for electronic transactions and within three years new diagnostic and procedure code sets – a regulatory challenge being dubbed "healthcare's Y2K."
Researchers at the University of California, San Diego School of Medicine developed a method to expand the types of chromosomal abnormalities that noninvasive prenatal testing (NIPT) can detect. The study, published November 9 by Proceedings of the National Academy of Sciences, uses a semiconductor sequencing platform to identify small chromosomal deletions or duplications, such as occur in Cri du Chat Syndrome and DiGeorge Syndrome, with a simple blood test from the expectant mother.
Zafgen, Inc., the world's first biopharmaceutical company dedicated to addressing the unmet need of severely obese patients, today announced new data from two Phase 1 studies of beloranib, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed significant weight loss and improvements in cardiometabolic risk markers in severely obese women.
Cronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world's leading experts on lung disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Corrina J Reinek, APRN Po Box 2147, Fort Myers, FL 33902-2147 Ph: (239) 343-2606 | Corrina J Reinek, APRN 2776 Cleveland Ave, Fort Myers, FL 33901-5864 Ph: (239) 343-2606 |
News Archive
DST Health Solutions, LLC today announced its 5-I Compliance Accelerator Program, designed to help health plans successfully prepare major business systems for compliance with upcoming federal regulations. Within two years, the Centers for Medicare & Medicaid Services (CMS) will require healthcare organizations to begin using new standards for electronic transactions and within three years new diagnostic and procedure code sets – a regulatory challenge being dubbed "healthcare's Y2K."
Researchers at the University of California, San Diego School of Medicine developed a method to expand the types of chromosomal abnormalities that noninvasive prenatal testing (NIPT) can detect. The study, published November 9 by Proceedings of the National Academy of Sciences, uses a semiconductor sequencing platform to identify small chromosomal deletions or duplications, such as occur in Cri du Chat Syndrome and DiGeorge Syndrome, with a simple blood test from the expectant mother.
Zafgen, Inc., the world's first biopharmaceutical company dedicated to addressing the unmet need of severely obese patients, today announced new data from two Phase 1 studies of beloranib, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed significant weight loss and improvements in cardiometabolic risk markers in severely obese women.
Cronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world's leading experts on lung disease.
› Verified 4 days ago
Dr. Otniel Hernandez, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3677 Central Ave Ste B, Fort Myers, FL 33901 Phone: 239-790-1263 Fax: 239-790-1074 | |
Pamela Lynn Cooper, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 12734 Kenwood Ln, Suite 84, Fort Myers, FL 33907 Phone: 866-936-5250 | |
April Stewart Stowers, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13782 Plantation Rd Ste 201, Fort Myers, FL 33912 Phone: 239-343-1100 Fax: 239-343-1101 | |
Carmalee Martin, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9341 Via San Giovani St, Fort Myers, FL 33905 Phone: 249-297-4864 | |
Sarah Elizabeth Long, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9241 Park Royal Dr, Fort Myers, FL 33908 Phone: 239-985-2700 | |
Ms. Susan Ann Sherman, MS, ARNP, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3900 Broadway, Suite B-1, Fort Myers, FL 33901 Phone: 239-939-2808 Fax: 239-939-4794 | |
Tracy Heather Zielinski, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4219 Lemongrass Dr, Fort Myers, FL 33916 Phone: 239-272-7705 |